tiprankstipranks
Advertisement

NOBL - ETF AI Analysis

Compare

Top Page

NOBL

ProShares S&P 500 Dividend Aristocrats ETF (NOBL)

Rating:71Outperform
Price Target:
NOBL, the ProShares S&P 500 Dividend Aristocrats ETF, has an overall rating that suggests it is a generally solid, but not flawless, dividend-focused fund. Strong contributors like Caterpillar, T. Rowe Price, and ADP support the rating through robust financial performance, positive earnings commentary, and strategic growth initiatives, while weaker names such as JM Smucker and some holdings with bearish technical trends and leverage issues slightly weigh on the fund. The main risk factor is that several holdings show signs of high valuation, leverage, or bearish momentum, which could add volatility even though the overall portfolio remains diversified.
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered strong gains so far this year, showing solid momentum for investors.
Resilient Dividend Aristocrat Holdings
Many of the top holdings, such as Archer Daniels Midland and WW Grainger, have shown strong performance, supporting the fund’s overall returns.
Broad Sector Diversification
The ETF spreads its investments across several sectors, including consumer defensive, industrials, financials, and health care, which helps reduce reliance on any single industry.
Negative Factors
Single-Country Concentration
Almost all of the ETF’s assets are invested in U.S. companies, offering little geographic diversification.
Mixed Performance Among Top Holdings
While many top positions are performing well, some holdings like Automatic Data Processing have been weaker, which can drag on overall results.
Moderate Expense Ratio
The fund’s fees are not extremely high but are also not among the lowest, meaning a small portion of returns goes toward costs each year.

NOBL vs. SPDR S&P 500 ETF (SPY)

NOBL Summary

NOBL is an ETF that follows the S&P 500 Dividend Aristocrats index, which focuses on U.S. companies that have raised their dividends every year for at least 25 years. It holds well-known names like AbbVie and Archer Daniels Midland, spread across many sectors such as consumer goods, industrials, and healthcare. Investors might consider NOBL if they want a mix of potential long-term growth and steady dividend income from established, large companies. A key risk is that the fund still moves up and down with the stock market, so your investment value can decline during market downturns.
How much will it cost me?The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has an expense ratio of 0.35%, meaning you’ll pay $3.50 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it is actively managed to focus on companies with a strong history of increasing dividends, which requires more research and oversight.
What would affect this ETF?The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) could benefit from stable economic conditions and a focus on dividend-paying companies, as these firms tend to perform well during periods of market uncertainty. However, rising interest rates or economic slowdowns could negatively impact sectors like Consumer Defensive and Industrials, which make up a significant portion of the ETF's holdings. Additionally, regulatory changes or challenges in the U.S. market, where the ETF is heavily focused, could pose risks to its performance.

NOBL Top 10 Holdings

NOBL is powered by a steady crew of U.S. dividend stalwarts, with industrials and consumer defensive names steering the ship. Nucor and Archer Daniels Midland have been rising, giving the fund a solid lift, while AbbVie and General Dynamics add steady health care and defense exposure with generally supportive trends. On the flip side, West Pharmaceutical and Hormel Foods have been more mixed lately, occasionally losing steam and trimming some of the upside. Overall, the ETF leans on resilient, cash-generating businesses rather than flashy growth stories.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Roper Technologies1.66%$194.13M$39.56B-27.70%
71
Outperform
Erie Indemnity Company1.64%$191.42M$11.27B-30.99%
70
Outperform
Automatic Data Processing1.57%$182.77M$106.51B-11.31%
70
Outperform
Nucor1.56%$181.88M$58.60B85.54%
74
Outperform
Brown-Forman B1.55%$181.41M$13.27B-0.07%
74
Outperform
International Business Machines1.55%$181.25M$210.71B-10.56%
79
Outperform
Becton Dickinson1.54%$180.33M$45.64B-6.10%
67
Neutral
Brown & Brown1.54%$179.54M$23.56B-23.68%
76
Outperform
Factset Research1.53%$179.00M$9.36B-32.74%
78
Outperform
Emerson Electric Company1.53%$178.93M$83.91B5.67%
76
Outperform

NOBL Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
55.57
Positive
100DMA
54.34
Positive
200DMA
53.51
Positive
Market Momentum
MACD
RSI
STOCH
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For NOBL, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 56.94, equal to the 50-day MA of 55.57, and equal to the 200-day MA of 53.51, indicating a bullish trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NOBL.

NOBL Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$11.91B0.35%
71
Outperform
$986.86B0.03%
74
Outperform
$863.10B0.03%
74
Outperform
$776.18B0.09%
74
Outperform
$450.09B0.18%
73
Outperform
$158.18B0.02%
74
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NOBL
ProShares S&P 500 Dividend Aristocrats ETF
57.08
7.09
14.18%
VOO
Vanguard S&P 500 ETF
IVV
iShares Core S&P 500 ETF
SPY
SPDR S&P 500 ETF Trust
QQQ
Invesco QQQ Trust
SPYM
State Street SPDR Portfolio S&P 500 ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement